S&P 500

5.999,91

-1,66%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Diversos
LSE
Inter-amer 30 (BC43)
Inter-amer 30 (BC43) Notícias

BC43

Inter-amer 30 (BC43)

Inter-amer 30

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:LSE:BC43

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
13/11/2002	12:09	UK Regulatory	Rebecca O. Kendall Announces Retirement; Robert A. Armitage Promoted to Lilly Senior Vice President, General Counsel	LSE:BC43	Inter-amer 30
09/11/2002	07:30	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
08/11/2002	10:30	UK Regulatory	Lilly Outlines to Wall Street Its Strategy To Realize Its Growth Opportunities and Deliver Superior Earnings Growth Over the Lon	LSE:BC43	Inter-amer 30
29/10/2002	11:00	UK Regulatory	Cymbalta Data Suggest Rapid and Sustained Response by First Week of Therapy	LSE:BC43	Inter-amer 30
23/10/2002	09:10	UK Regulatory	3rd Quarter Results	LSE:BC43	Inter-amer 30
22/10/2002	04:01	UK Regulatory	Alimta Continues To Show Versatility in Treating Different Cancers	LSE:BC43	Inter-amer 30
21/10/2002	17:15	UK Regulatory	Dividend Declaration	LSE:BC43	Inter-amer 30
18/10/2002	04:00	UK Regulatory	Combining Innovative Therapies for Optimal Cancer Care; Effectiveness of Gemzar-Based Combination Regimens is Topic of Workshop	LSE:BC43	Inter-amer 30
01/10/2002	11:10	UK Regulatory	Newly Published Study Demonstrates Sustained Efficacy of Evista -raloxifene HCl- in Reducing Risk of Spinal Fractures	LSE:BC43	Inter-amer 30
25/09/2002	18:59	UK Regulatory	Lilly Asserts The New England Journal of Medicine ``Sounding Board'' Opinion Article Attempts to Turn Back the Clock on Care of	LSE:BC43	Inter-amer 30
24/09/2002	18:39	UK Regulatory	Re Alliance	LSE:BC43	Inter-amer 30
20/09/2002	10:07	UK Regulatory	Statement re	LSE:BC43	Inter-amer 30
17/09/2002	11:34	UK Regulatory	Lilly Launches World's Largest Severe Sepsis Clinical Trial; 11,000 Patients to be Enrolled in Study of Xigris Use in Patients w	LSE:BC43	Inter-amer 30
16/09/2002	14:02	UK Regulatory	FDA Issues Approvable Letter for Lilly's Cymbalta for Treatment of Depression; From the Makers of Prozac, Cymbalta Will Offer Ne	LSE:BC43	Inter-amer 30
16/09/2002	11:04	UK Regulatory	Miscellaneous	LSE:BC43	Inter-amer 30
03/09/2002	11:08	UK Regulatory	Tadalafil for the Treatment of Erectile Dysfunction Receives Positive Recommendation From the Australian Drug Evaluation Committ	LSE:BC43	Inter-amer 30
26/08/2002	16:11	UK Regulatory	Regulatory Approval	LSE:BC43	Inter-amer 30
14/08/2002	10:29	UK Regulatory	FDA Issues Approvable Letter for Strattera for ADHD; Strattera Would Give Patients, Families and Physicians a New Treatment Opti	LSE:BC43	Inter-amer 30
01/08/2002	04:23	UK Regulatory	Lilly's Xigris Becomes First and Only Medical Product Approved for BIPA Payment in Medicare Patients	LSE:BC43	Inter-amer 30
25/07/2002	17:03	UK Regulatory	Lilly ICOS LLC	LSE:BC43	Inter-amer 30
30/04/2002	12:55	UK Regulatory	Financial Expectations-Update	LSE:BC43	Inter-amer 30
16/04/2002	06:25	UK Regulatory	Dividend	LSE:BC43	Inter-amer 30
15/04/2002	12:35	UK Regulatory	1st Quarter Results	LSE:BC43	Inter-amer 30
15/04/2002	04:00	RNS Non-Regulatory	Collaboration Extended	LSE:BC43	Lilly (Eli) & Co
25/03/2002	08:13	UK Regulatory	Annual Report and Accts etc	LSE:BC43	Inter-amer 30
20/03/2002	12:08	RNS Non-Regulatory	Translational Medicine Award	LSE:BC43	Lilly (Eli) & Co
20/03/2002	04:00	UK Regulatory	Research Update	LSE:BC43	Inter-amer 30
12/03/2002	15:07	RNS Non-Regulatory	Patient Assistance Program	LSE:BC43	Lilly (Eli) & Co
05/03/2002	06:08	UK Regulatory	2002 Xigris Sales	LSE:BC43	Inter-amer 30
20/02/2002	04:05	UK Regulatory	Directorate Change	LSE:BC43	Inter-amer 30